Phase 3 Trials of Tapinarof Cream for Plaque Psoriasis
Phase 3 Trials of Tapinarof Cream for Plaque Psoriasis
About this item
Full title
Author / Creator
Lebwohl, Mark G , Stein Gold, Linda , Strober, Bruce , Papp, Kim A , Armstrong, April W , Bagel, Jerry , Kircik, Leon , Ehst, Benjamin , Hong, H. Chih-ho , Soung, Jennifer , Fromowitz, Jeff , Guenthner, Scott , Piscitelli, Stephen C , Rubenstein, David S , Brown, Philip M , Tallman, Anna M and Bissonnette, Robert
Publisher
United States: Massachusetts Medical Society
Journal title
Language
English
Formats
Publication information
Publisher
United States: Massachusetts Medical Society
Subjects
More information
Scope and Contents
Contents
In two identical trials of treatment for psoriasis with the topical aryl hydrocarbon receptor–modulating agent tapinarof, clearance or near-clearance of lesions occurred in a larger proportion of patients who used tapinarof cream than of those who used placebo. Side effects included folliculitis, contact dermatitis, and headache.
Alternative Titles
Full title
Phase 3 Trials of Tapinarof Cream for Plaque Psoriasis
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_2614228682
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2614228682
Other Identifiers
ISSN
0028-4793
E-ISSN
1533-4406
DOI
10.1056/NEJMoa2103629
